Table of contents
28 December 2015
28 December 2015
Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer – 28 December 2015 – Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. We estimated the global prevalence, incidence, progression, and outcomes of NAFLD and nonalcoholic steatohepatitis (NASH). PubMed/MEDLINE were searched from 1989 to 2015 for terms involving epidemiology and progression of NAFLD.
Pi‐Xiao Wang, Xiao‐Jing Zhang, Hongliang Li – 28 December 2015
Isabelle Desombere, Samira Fafi‐Kremer, Freya Van Houtte, Patrick Pessaux, Ali Farhoudi, Laura Heydmann, Lieven Verhoye, Sarah Cole, Jane A. McKeating, Geert Leroux‐Roels, Thomas F. Baumert, Arvind H. Patel, Philip Meuleman – 28 December 2015 – End‐stage liver disease (ESLD) caused by hepatitis C virus (HCV) infection is a major indication for liver transplantation. However, immediately after transplantation, the liver graft of viremic patients universally becomes infected by circulating virus, resulting in accelerated liver disease progression.
28 December 2015
28 December 2015
Shinichiro Yokota, Osamu Yoshida, Yoshihiro Ono, David A. Geller, Angus W. Thomson – 28 December 2015 – The surgically demanding mouse orthotopic liver transplant model was first described in 1991. It has proved to be a powerful research tool for the investigation of liver biology, tissue injury, the regulation of alloimmunity and tolerance induction, and the pathogenesis of specific liver diseases.
28 December 2015
Joseph Ralph Kallini, Ahmed Gabr, Laura Kulik, Daniel Ganger, Robert Lewandowski, Bartley Thornburg, Riad Salem – 28 December 2015
Pi‐Xiao Wang, Xiao‐Jing Zhang, Hongliang Li – 28 December 2015